Novartis AG ADR
Yahoo Finance • 23 hours ago
Ramsay Générale de Santé (ENXTPA:GDS) Stock May Trade At A Discount To Sales
Ramsay Générale de Santé has spent the past few years under pressure, yet the shares have climbed modestly over the past year, which puts a fresh spotlight on what investors are paying for its sales today. With the stock changing hands aro... Full story
Yahoo Finance • yesterday
Why Ramsay Générale de Santé (ENXTPA:GDS) Is Back In The Spotlight
Ramsay Générale de Santé (ENXTPA:GDS) has called a board meeting for 6 October 2026 to review the auditors' certification report on its consolidated accounts, a routine governance step that remains important for equity holders. Against th... Full story
Yahoo Finance • 2 days ago
Melexis (ENXTBR:MELE) Stock May Be 27% Undervalued As Cash Flow Holds Up
Melexis has delivered a mixed share price record over recent years, which raises a direct question for anyone looking at the stock today. Is the current market valuation really supported by the cash flows the business can generate over tim... Full story
Yahoo Finance • 2 days ago
Suominen’s financial reporting in 2027
Suominen Corporation Suominen Corporation's stock exchange release on October 9, 2026, at 11:00 a.m. (EEST) Suominen Corporation will publish its financial reports in 2027 as follows: March 2, 2027 – Financial Statements Bulletin for 20... Full story
Yahoo Finance • 2 days ago
Barclays downgrades 2 European airline stocks into September quarter results
Investing.com -- Barclays downgraded Ryanair and Norwegian Air Shuttle to Equal Weight from Overweight, saying persistently high fuel prices threaten fourth-quarter and 2027 profits across European airlines. Before you buy NVIDIA: our AI... Full story
Yahoo Finance • 3 days ago
INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 2026
Klépierre INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 20261 Paris – October 8, 2026 NUMBER OF SHARES AS OF SEPTEMBER 30, 2026 Date 09/30/2026 Company name Klépierre Trading place Euronex... Full story
Yahoo Finance • 3 days ago
Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's
Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response. Continue Reading... Full story
Yahoo Finance • 3 days ago
Pheochromocytoma and Paraganglioma (PCPG) Market to Reach US$670 Million by 2036 at 7.3% CAGR, Driven by Targeted and Radioligand Therapies
Company Logo Up from about US$300 million in 2025 across the US, EU4, UK and Japan, as Merck's WELIREG, the first oral targeted PCPG therapy, faces pipeline rivals from Novartis, Jazz and Perspective. Dublin, Oct. 08, 2026 (GLOBE NEWSWIR... Full story
Yahoo Finance • 4 days ago
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value
(Bloomberg) -- Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. M... Full story
Yahoo Finance • 4 days ago
VERBUND AG: Stefan Waldner Appointed Chief Financial Officer
VIENNA, AUSTRIA - October 7, 2026 (NEWMEDIAWIRE) - The Supervisory Board of VERBUND AG today appointed Stefan Waldner (49) as Chief Financial Officer (CFO) and a member of the Management Board. His appointment is for a two-year term, with... Full story
Yahoo Finance • 4 days ago
Is Novartis (SWX:NOVN) Undervalued After New MS Trial Data Took Center Stage?
Novartis (SWX:NOVN) just put multiple sclerosis front and center for investors, flagging 46 abstracts for MSToronto2026, including late breaking Phase III REMODEL data on remibrutinib and new Kesimpta pediatric results. At a share price o... Full story
Yahoo Finance • 4 days ago
Norwegian Air Shuttle (OB:NAS) Adds 737 8 Capacity On A Fair Value Gap Narrative
Norwegian Air Shuttle's New 737-8 Deliveries Set Up Fresh Capacity Questions CDB Aviation has delivered the first of four Boeing 737-8 jets to Norwegian Air Shuttle (OB:NAS), kicking off a new leasing partnership and adding aircraft tied... Full story
Yahoo Finance • 4 days ago
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Novartis Pharma AG In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21 SD is most prevalent type of chronic inducible urticaria (CIndU)2;... Full story
Yahoo Finance • 4 days ago
Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases
Matchpoint Therapeutics Financing co-led by Nextech Invest and Norwest, with participation from new and existing investors Proceeds to support clinical development of MPT-062, an oral first-in-class T cell modulator, to begin in 2027 WA... Full story
Yahoo Finance • 4 days ago
Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
Novartis Pharma AG Late-breaking data from positive Phase III REMODEL-1/-2 trials will show efficacy and safety profile of remibrutinib in RMS Novartis to hold virtual investor event highlighting REMODEL data and remibrutinib in MS Phas... Full story
Yahoo Finance • 4 days ago
Pacibekitug Market Size, Sales Forecast, and Competitive Analysis - 2034 | Phase III-Ready IL-6 Therapy Targets Major Cardiovascular Growth Opportunities in the 7MM
Company Logo Pacibekitug combines strong Phase II efficacy, quarterly dosing, a large residual-risk population and Novartis' reach—key drivers of adoption and market positioning. Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Pacibekitug Sal... Full story
Yahoo Finance • 5 days ago
Information Regarding the Total Voting Rights and Shares of Gecina as of September 30, 2026 (1)
PARIS, October 06, 2026--(BUSINESS WIRE)--Regulatory News: Gecina (Paris:GFC): Date Total number of shares Total number of voting rights September 2026 76,792,337 Total number of voting rights (including treasury shares): 76,792,337 To... Full story
Yahoo Finance • 5 days ago
Klépierre: Disclosure of transactions in own shares from September 30 to October 2, 2026
Klépierre DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM SEPTEMBER 30 TO OCTOBER 2, 2026 Paris – October 6, 2026 As part of the implementation of the treasury share buyback program authorized by the Shareholders' General Meeting Meeting... Full story
Yahoo Finance • 5 days ago
RAMSAY SANTE : Final annual results as of 30 June 2026
RAMSAY SANTE PRESS RELEASE Paris, 6th October 2026 Annual results at the end of June 2026 Revenue growth and disciplined efficiency drive stronger operational profitability Capital Markets Day on 17th September: Ramsay Santé outline... Full story
Yahoo Finance • 5 days ago
SAP Puts the Autonomous Enterprise to Work
Joule Work, Joule Assistants and SAP Business AI Platform help organizations turn business AI into trusted outcomes across every core function. LAS VEGAS, Oct. 6, 2026 /PRNewswire/ -- SAP SE (NYSE: SAP) today showcased the Autonomous Ente... Full story
- SAP